Global Cord Blood (CORBF) Competitors $1.15 +0.10 (+9.52%) As of 10:15 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock CORBF vs. TALK, INNV, CELC, SBC, PSNL, VMD, DCGO, LFMD, SERA, and AIRSShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include Talkspace (TALK), InnovAge (INNV), Celcuity (CELC), SBC Medical Group (SBC), Personalis (PSNL), Viemed Healthcare (VMD), DocGo (DCGO), LifeMD (LFMD), Sera Prognostics (SERA), and AirSculpt Technologies (AIRS). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Talkspace InnovAge Celcuity SBC Medical Group Personalis Viemed Healthcare DocGo LifeMD Sera Prognostics AirSculpt Technologies Talkspace (NASDAQ:TALK) and Global Cord Blood (NYSE:CORBF) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, community ranking, earnings, profitability, dividends, media sentiment and analyst recommendations. Do insiders and institutionals hold more shares of TALK or CORBF? 57.4% of Talkspace shares are owned by institutional investors. 21.7% of Talkspace shares are owned by insiders. Comparatively, 0.5% of Global Cord Blood shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer TALK or CORBF? Talkspace currently has a consensus target price of $4.50, indicating a potential upside of 71.10%. Given Talkspace's stronger consensus rating and higher possible upside, research analysts plainly believe Talkspace is more favorable than Global Cord Blood.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Talkspace 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 2 Strong Buy rating(s) 3.00Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community favor TALK or CORBF? Talkspace received 6 more outperform votes than Global Cord Blood when rated by MarketBeat users. CompanyUnderperformOutperformTalkspaceOutperform Votes642.86% Underperform Votes857.14% Global Cord BloodN/AN/A Is TALK or CORBF more profitable? Talkspace has a net margin of 0.61% compared to Global Cord Blood's net margin of 0.00%. Talkspace's return on equity of 0.98% beat Global Cord Blood's return on equity.Company Net Margins Return on Equity Return on Assets Talkspace0.61% 0.98% 0.84% Global Cord Blood N/A N/A N/A Which has more risk and volatility, TALK or CORBF? Talkspace has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Comparatively, Global Cord Blood has a beta of -0.64, suggesting that its stock price is 164% less volatile than the S&P 500. Does the media favor TALK or CORBF? In the previous week, Talkspace had 7 more articles in the media than Global Cord Blood. MarketBeat recorded 7 mentions for Talkspace and 0 mentions for Global Cord Blood. Talkspace's average media sentiment score of 0.71 beat Global Cord Blood's score of 0.00 indicating that Talkspace is being referred to more favorably in the media. Company Overall Sentiment Talkspace Positive Global Cord Blood Neutral Which has better valuation & earnings, TALK or CORBF? Global Cord Blood has higher revenue and earnings than Talkspace. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTalkspace$187.59M2.36-$19.18M$0.01263.00Global Cord Blood$196.12M0.71$79.04MN/AN/A SummaryTalkspace beats Global Cord Blood on 14 of the 16 factors compared between the two stocks. Remove Ads Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$139.78M$1.96B$5.24B$17.69BDividend YieldN/A7.11%4.87%3.79%P/E RatioN/A15.1421.2029.95Price / Sales0.713.95356.3524.26Price / Cash1.409.3238.1617.54Price / BookN/A4.066.234.13Net Income$79.04M$87.49M$3.20B$1.02B7 Day Performance43.75%-2.82%-8.32%-8.68%1 Month PerformanceN/A-5.41%-3.36%-9.64%1 Year Performance-14.81%-22.87%2.72%-4.93% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$1.15+9.5%N/A-22.2%$139.78M$196.12M0.001,200TALKTalkspace3.9587 of 5 stars$2.56-2.7%$4.38+70.9%-26.6%$431.20M$187.59M256.26500Analyst ForecastShort Interest ↓News CoverageGap DownINNVInnovAge1.3882 of 5 stars$2.98-0.7%$5.00+67.8%-38.5%$403.03M$806.61M-15.682,000Positive NewsCELCCelcuity1.3641 of 5 stars$10.11-1.3%$30.17+198.4%-55.8%$375.38MN/A-3.8740Earnings ReportAnalyst ForecastAnalyst RevisionGap DownSBCSBC Medical GroupN/A$3.19-2.7%N/AN/A$328.64M$223.34M0.00N/AEarnings ReportAnalyst RevisionNews CoverageGap UpPSNLPersonalis4.0545 of 5 stars$3.51-3.0%$7.80+122.2%+144.4%$309.80M$84.61M-2.09400Positive NewsGap DownVMDViemed Healthcare0.9918 of 5 stars$7.28+0.1%N/A-21.0%$287.72M$224.26M26.96630Positive NewsGap DownDCGODocGo2.8287 of 5 stars$2.64flat$4.89+85.3%-33.2%$269.24M$616.56M9.432,920Short Interest ↓Gap DownLFMDLifeMD1.701 of 5 stars$5.44-0.2%$11.43+110.1%-47.5%$242.54M$212.45M-8.50230Short Interest ↑Gap DownSERASera Prognostics0.3829 of 5 stars$3.68+4.0%N/A-66.9%$138.60M$77,000.00-3.72120Gap DownAIRSAirSculpt Technologies1.1739 of 5 stars$2.34+2.2%$3.75+60.3%-64.6%$137.07M$180.35M-16.71240Short Interest ↑Gap Down Remove Ads Related Companies and Tools Related Companies TALK Competitors INNV Competitors CELC Competitors SBC Competitors PSNL Competitors VMD Competitors DCGO Competitors LFMD Competitors SERA Competitors AIRS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CORBF) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
